Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3137 Triple Negative Breast Neoplasms 513 Ovarian Neoplasms 226 Colorectal Neoplasms 191 Carcinoma, Non-Small-Cell Lung 190 Prostatic Neoplasms 183 Neoplasms 176 Lung Neoplasms 164 Neoplasm Metastasis 162 Melanoma 118 Stomach Neoplasms 114 Pancreatic Neoplasms 112 Endometrial Neoplasms 106 Uterine Cervical Neoplasms 93 Squamous Cell Carcinoma of Head and Neck 88 Carcinoma, Intraductal, Noninfiltrating 82 Head and Neck Neoplasms 81 Colonic Neoplasms 81 Sarcoma 63 Breast Carcinoma In Situ 62 Urinary Bladder Neoplasms 60 Carcinoma, Renal Cell 60 Motor Activity 59 Esophageal Neoplasms 58 Brain Neoplasms 50 Lymphedema 44 Breast Cancer Female 41 Advanced Breast Cancer 40 Liver Neoplasms 39 HER2-positive Breast Cancer 38

Interventions

pertuzumab 1 azeliragon 1 Trastuzumab 1 Docetaxel 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Related Cognitive Decline × Breast × 1 year × Clear all

NCT05256745 2025-12-24

RAGE

Georgetown University

Phase 1/2 Recruiting

Cancer Related Cognitive Decline

Data powered by HemOnc (CC BY 4.0) Colophon ⚡